Abstract:Guided by molecular docking, a commonly used open-chain linker was cyclized into a five-membered pyrrolidine to lock the overall conformation of the propeller-shaped molecule. Different substituents were introduced into the pyrrolidine moiety to block oxidative metabolism. Surprisingly, it was found that a small methyl substituent could be used to alleviate the oxidative metabolism of pyrrolidine while maintaining or enhancing potency, which could be described as a "magic methyl". Further optimization around the "3rd blade" of the propeller led to identification of a series of potent and selective PI3Kδ inhibitors. Among them, compound 50 afforded an optimum balance of PK profiles and potency. Oral administration of 50 attenuated the arthritis severity in a dose-dependent manner in a collagen-induced arthritis model without obvious toxicity. Furthermore, 50 demonstrated excellent pharmacokinetic properties with high bioavailability, suggesting that 50 might be an acceptable candidate for treatment of inflammatory diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00004?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00004</a>.Binding affinities of 50 with 164 kinases (Table S1); predicted results of compound 43 from the CYP3A4, CYP2D6, and CYP2C9 models, respectively, in SMARTCyp (Tables S2–S4); effects of compound 50 and idelalisib on normal cell viability (Table S5); binding free energy (ΔGbindcal) for idelalisib/PI3Kδ complexes (Table S6); binding free energy (ΔGbindcal) for compound 50/PI3Kδ complexes (Table S7); cocrystal structure of 1 in PI3Kδ (Figure S1); docking model of compound 29 in PI3Kδ (Figure S2); pre-experiments of selected compounds and dexamethasone in collagen-induced arthritis models (Figure S3); snapshots of the idelalisib/PI3Kδ complex along the dynamic simulation time for 100th, 200th, 300th, 400th, and 500th ns (Figure S4); snapshots of the compound 50/PI3Kδ complex along the dynamic simulation time at 100th, 200th, 300th, 400th, and 500th ns (Figure S5); therapeutic efficacy of 50 in mice-established collagen-induced arthritis (Figure S6); HPLC spectra of compound 50 (Figure S6); 1H NMR spectra of compounds 26, 30, 45, 46, 47, 49, and 50 (Figures S8, S9, S10, S11, S12, S13, and S14, respectively); and biological assay methods: (1) kinase profile assay and IC50 test; (2) class I PI3K isoform-selective cellular assays (SKOV-3, 786-O, RAW 264.7, and RAJI cell lines); (3) basophil activation assay in HWB; (4) B cell activation assay in HWB; (5) primary human T-cell proliferation assays; (6) microsome stability assay; (7) pharmacokinetic study; (8) collagen-induced arthritis (CIA) model and treatment; and (9) histological examination (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00004/suppl_file/jm1c00004_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00004/suppl_file/jm1c00004_si_003.csv">CSV</a>)PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0">4XE0</a> was used for docking in PI3Kδ of compounds 10, 29, 43, and 50 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00004/suppl_file/jm1c00004_si_002.zip">ZIP</a>)This article has not yet been cited by other publications.

Conformationally Constrained Analogues of Diacylglycerol. 18. the Incorporation of a Hydroxamate Moiety into Diacylglycerol-Lactones Reduces Lipophilicity and Helps Discriminate Between Sn-1 and Sn-2 Binding Modes to Protein Kinase C (PK-C). Implications for Isozyme Specificity.

Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?

Retraction of “A New Synthetic Route to Avibactam: Lipase Catalytic Resolution and the Simultaneous Debenzylation/Sulfation”

Synthesis and evaluation of iodinated analogues of diacylglycerols as potential probes for protein kinase C

Elucidating the Binding Mechanism of LPA Species and Analogs in an LPA4 Receptor Homology Model

Response to Comment on “PCB Association with Model Phospholipid Bilayers”

From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational Profiling

HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates

Synthesis and Biological Evaluation of Lysophosphatidic Acid Analogues Using Conformational Restriction and Bioisosteric Replacement Strategies

An sn-2 regioselective lipase with cis-fatty acid preference from Cordyceps militaris: Biochemical characterization and insights into its regioselective mechanism

Crystal structure of a mono- and diacylglycerol lipase from Malassezia globosa reveals a novel lid conformation and insights into the substrate specificity.

Molecular basis for substrate selectivity of a mono- and diacylglycerol lipase from Malassezia globosa

Discovery of a novel class of diacylglycerol acyltransferase 2 inhibitors with a 1H-pyrrolo[2,3-b]pyridine core

A simple homogeneous scintillation proximity assay for acyl-coenzyme A:diacylglycerol acyltransferase

Malassezia Globosa MgMDL2 Lipase: Crystal Structure and Rational Modification of Substrate Specificity.

Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases

Pancreatic Triglyceride Lipase Inhibitors Derived from Natural Products: How to Dig into the Truth

Correction to “encapsulated Microstructures of Beneficial Functional Lipids and Their Applications in Foods and Biomedicines”

Characterization and Reshaping of a Large and Hydrophobic Nucleophile Pocket in Lipases/Acyltransferases

Neurosteroid Analogues. 8. Structure−Activity Studies of <i>N</i>-Acylated 17a-Aza-D-homosteroid Analogues of the Anesthetic Steroids (3α,5α)- and (3α,5β)-3-Hydroxypregnan-20-one

An Adamantyl-Substituted Retinoid-Derived Molecule That Inhibits Cancer Cell Growth and Angiogenesis by Inducing Apoptosis and Binds to Small Heterodimer Partner Nuclear Receptor: Effects of Modifying Its Carboxylate Group on Apoptosis, Proliferation, and Protein-Tyrosine Phosphatase Activity